Jeffrey M. Dayno Harmony Biosciences Holdings, Inc. (HRMY) insider trading activity

Jeffrey M. Dayno is PRESIDENT, CEO of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 0 shares of HRMY, which is worth approximately $0. The most recent transaction as insider was on Nov 03, 2022, when has been sold 15,000 shares (Common Stock) at a price of $60.02 per share, resulting in proceeds of $900,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jeffrey M. Dayno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 03 2022	SELL Open market or private sale	$900,300 $60.02 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$123,300 $8.22 p/Share	15,000 Added 50.0%	15,000 Common Stock
Nov 01 2022	SELL Open market or private sale	$826,500 $55.1 p/Share	15,000 Reduced 100.0%	0 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$123,300 $8.22 p/Share	15,000 Added 50.0%	15,000 Common Stock
Oct 19 2021	SELL Open market or private sale	$790,790 $43.45 p/Share	18,200 Reduced 100.0%	0 Common Stock
Oct 19 2021	BUY Exercise of conversion of derivative security	$149,604 $8.22 p/Share	18,200 Added 81.61%	4,101 Common Stock
Oct 06 2021	SELL Open market or private sale	$72,180 $40.1 p/Share	1,800 Reduced 100.0%	0 Common Stock
Oct 06 2021	BUY Exercise of conversion of derivative security	$14,796 $8.22 p/Share	1,800 Added 50.0%	1,800 Common Stock
Sep 07 2021	SELL Open market or private sale	$375,800 $37.58 p/Share	10,000 Reduced 100.0%	0 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$82,200 $8.22 p/Share	10,000 Added 50.0%	10,000 Common Stock
Aug 27 2021	SELL Open market or private sale	$275,690 $35.16 p/Share	7,841 Reduced 100.0%	0 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	$64,453 $8.22 p/Share	7,841 Added 50.0%	7,841 Common Stock
Aug 26 2021	SELL Open market or private sale	$75,587 $35.01 p/Share	2,159 Reduced 100.0%	0 Common Stock
Aug 26 2021	BUY Exercise of conversion of derivative security	$17,747 $8.22 p/Share	2,159 Added 50.0%	2,159 Common Stock
Aug 10 2021	SELL Open market or private sale	$300,589 $30.21 p/Share	9,950 Reduced 100.0%	0 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$81,789 $8.22 p/Share	9,950 Added 50.0%	9,950 Common Stock
Jul 22 2021	SELL Open market or private sale	$1,500 $30.0 p/Share	50 Reduced 100.0%	0 Common Stock
Jul 22 2021	BUY Exercise of conversion of derivative security	$411 $8.22 p/Share	50 Added 50.0%	50 Common Stock

JMD

Jeffrey M. Dayno

PRESIDENT, CEO

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Value

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Harmony Biosciences Holdings, Inc.

Track Activities on HRMY

Account